Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer

PURPOSE: Research has revealed that some patients who develop resistance to the first taxane treatment exhibit a moderate response to the second taxane treatment (incomplete cross-resistance between paclitaxel and docetaxel). However, which patients are most likely to respond to the second treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Hiroo, Saijo, Ken, Komine, Keigo, Kawamura, Yoshifumi, Hiraide, Sakura, Umegaki, Sho, Okada, Yoshinari, Ohuchi, Kota, Sato, Yuko, Takahashi, Masahiro, Takahashi, Shin, Shirota, Hidekazu, Takahashi, Masanobu, Ishioka, Chikashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149899/
https://www.ncbi.nlm.nih.gov/pubmed/30271211
http://dx.doi.org/10.2147/CMAR.S170948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149899/
https://www.ncbi.nlm.nih.gov/pubmed/30271211
http://dx.doi.org/10.2147/CMAR.S170948

Ejemplares similares